In conclusion, our research showed that the barbituric acid derivative BA-5 efficiently reduces hepatic stellate cells activation through inhibition of the NF-κB and TGF-β1 signalling pathways and further alleviates liver fibrosis formation in CCl4-induced mouse models. Here, NFKB1 is linked to Hepatic fibrosis.